11-hydroxy-delta(9)-tetrahydrocannabinol and ALS - Amyotrophic Lateral Sclerosis

11-hydroxy-delta(9)-tetrahydrocannabinol has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baldinger, R; Brenneisen, R; Fagagnini, S; Goldman, B; Joerger, M; Schneider, U; Weber, M; Wilkins, J	1

Trials

1 trial(s) available for 11-hydroxy-delta(9)-tetrahydrocannabinol and ALS - Amyotrophic Lateral Sclerosis

Article	Year
Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis. Drug metabolism letters, 2012, Jun-01, Volume: 6, Issue:2 Topics: Administration, Oral; Adult; Aged; Amyotrophic Lateral Sclerosis; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Dronabinol; Female; Heart Rate; Humans; Male; Middle Aged; Models, Biological; Prospective Studies	2012

Article

Year

Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis.

Drug metabolism letters, 2012, Jun-01, Volume: 6, Issue:2

Topics: Administration, Oral; Adult; Aged; Amyotrophic Lateral Sclerosis; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Dronabinol; Female; Heart Rate; Humans; Male; Middle Aged; Models, Biological; Prospective Studies

2012